Schuetz Thomas J.
SEC CIK 1591464 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | Pres, Dir | 6.60M | $1.17M | — | 33 | 2021-11-16 | 2026-02-08 |
Most active insiders at CMPX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anderman Jonathan | GC | $47.2K | — |
| 2 | Lerner Neil | CAO | $28.4K | — |
| 3 | Shin Barry | CFO | — | — |
| 4 | Schuetz Thomas J. | CEO, Dir | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-02-08 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $6.52 | -36.7K | 6.60M | -0.6% | -$239.2K | |
| 2026-01-12 | 2026-01-09 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $5.35 | -46.8K | 6.64M | -0.7% | -$250.3K | |
| D | 2026-01-05 | 2026-01-02 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | A - Grant | $5.17 | +250.0K | 6.69M | +4% | +$1.29M |
| 2025-11-18 | 2025-11-16 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $4.83 | -44.0K | 6.44M | -0.7% | -$212.6K | |
| 2025-05-27 | 2025-05-27 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.11 | +10.0K | 6.48M | +0.2% | +$21.1K | |
| 2025-02-11 | 2025-02-08 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $3.50 | -41.7K | 6.47M | -0.6% | -$145.9K | |
| 2025-01-13 | 2025-01-09 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $1.86 | -58.1K | 6.51M | -0.9% | -$108.0K | |
| 2024-02-09 | 2024-02-08 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | Pres, Dir | F - Tax | $1.45 | -44.8K | 6.57M | -0.7% | -$64.9K | |
| D | 2024-01-10 | 2024-01-09 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | Pres of R, D, Dir | A - Grant | $1.93 | +637.5K | 6.62M | +11% | +$1.23M |
| 2023-11-21 | 2023-11-17 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | F - Tax | $1.50 | -44.0K | 5.98M | -0.7% | -$66.0K | |
| 2023-03-10 | 2023-03-10 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.37 | +10.0K | 6.02M | +0.2% | +$33.7K | |
| 2023-02-27 | 2023-02-27 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.98 | +20.0K | 6.01M | +0.3% | +$79.6K | |
| 2023-02-15 | 2023-02-15 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.86 | +20.0K | 5.99M | +0.3% | +$77.2K | |
| D | 2023-02-09 | 2023-02-08 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | A - Grant | $0.00 | +500.0K | 5.97M | +9% | $0 |
| 2023-01-31 | 2023-01-31 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $4.05 | +20.0K | 5.47M | +0.4% | +$81.0K | |
| 2023-01-24 | 2023-01-24 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $4.19 | +20.0K | 5.45M | +0.4% | +$83.8K | |
| 2022-09-28 | 2022-09-28 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.32 | +10.0K | 5.43M | +0.2% | +$23.2K | |
| 2022-09-27 | 2022-09-26 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.27 | +15.0K | 5.42M | +0.3% | +$34.0K | |
| 2022-09-08 | 2022-09-07 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.03 | +15.0K | 5.41M | +0.3% | +$45.5K | |
| 2022-09-01 | 2022-09-01 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.83 | +15.0K | 5.39M | +0.3% | +$42.5K | |
| 2022-08-17 | 2022-08-17 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.05 | +15.0K | 5.38M | +0.3% | +$45.8K | |
| 2022-08-10 | 2022-08-10 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.64 | +15.0K | 5.36M | +0.3% | +$39.6K | |
| 2022-08-02 | 2022-08-01 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.58 | +15.0K | 5.35M | +0.3% | +$38.7K | |
| 2022-06-21 | 2022-06-21 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.80 | +20.0K | 5.33M | +0.4% | +$56.0K | |
| 2022-06-17 | 2022-06-16 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.34 | +20.0K | 5.31M | +0.4% | +$46.8K | |
| 2022-06-13 | 2022-06-13 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.29 | +30.0K | 5.29M | +0.6% | +$68.7K | |
| 2022-06-07 | 2022-06-06 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.83 | +30.0K | 5.26M | +0.6% | +$84.9K | |
| 2022-06-01 | 2022-06-01 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.03 | +20.0K | 5.23M | +0.4% | +$60.6K | |
| 2022-05-26 | 2022-05-26 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.04 | +20.0K | 5.21M | +0.4% | +$60.8K | |
| 2022-05-24 | 2022-05-23 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.72 | +18.4K | 5.19M | +0.4% | +$49.9K | |
| 2022-05-17 | 2022-05-17 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.47 | +20.2K | 5.17M | +0.4% | +$49.9K | |
| 2022-05-10 | 2022-05-10 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | P - Purchase | $1.80 | +27.8K | 5.15M | +0.5% | +$50.1K | |
| 2021-11-18 | 2021-11-16 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO, Dir | A - Grant | $0.00 | +600.0K | 5.13M | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations